Academic
Publications
Half-dose verteporfin photodynamic therapy for bullous variant of central serous chorioretinopathy: a case report

Half-dose verteporfin photodynamic therapy for bullous variant of central serous chorioretinopathy: a case report,10.1186/1752-1947-5-208,Journal of M

Half-dose verteporfin photodynamic therapy for bullous variant of central serous chorioretinopathy: a case report  
BibTex | RIS | RefWorks Download
Introduction  Central serous chorioretinopathy is characterized by serous neurosensory detachment of the macula and it usually resolves spontaneously with good visual prognosis. In some patients, however, the serous retinal detachment might be very extensive and can result in bullous exudative retinal detachment. We evaluated the use of half-dose verteporfin photodynamic therapy for the treatment of bullous retinal detachment in idiopathic central serous chorioretinopathy. Case presentation  We report the case of a 51-year-old Chinese man who presented with blurred vision in his right eye and superior visual field defect due to bullous variant of central serous chorioretinopathy. No improvement in vision and retinal detachment was noted after three months of observation and a short course of oral acetazolamide. He was then treated with half-dose verteporfin photodynamic therapy and his visual acuity improved from 20/70 to 20/25 within one month of treatment. Three months after photodynamic therapy, there was complete resolution of sub-retinal fluid and bullous retinal detachment. No recurrence of central serous chorioretinopathy was noted in three years of follow-up. Conclusion  We report the beneficial effect of photodynamic therapy with half-dose verteporfin as a treatment option for bullous retinal detachment caused by central serous chorioretinopathy.
Journal: Journal of Medical Case Reports - J Med Case Rep , vol. 5, no. 1, pp. 1-3, 2011
Cumulative Annual
View Publication
The following links allow you to view full publications. These links are maintained by other sources not affiliated with Microsoft Academic Search.